Wang, Sung-YinSung-YinWangTUNG-HUNG SUBANG-BIN CHENCHUN-JEN LIUCHEN-HUA LIUHUNG-CHIH YANGTAI-CHUNG TSENGPEI-JER CHENJIA-HORNG KAO2022-09-292022-09-292022-080929-6646https://scholars.lib.ntu.edu.tw/handle/123456789/623256Prothrombin Induced by Vitamin K Absence or Antagonist-II (PIVKA-II) is a diagnostic marker for hepatocellular carcinoma (HCC). Transarterial chemoembolization (TACE) is the standard management for intermediate stage HCC but lacks effective response predictors. We investigated the utility of PIVKA-II as a predictor of TACE response.enDes-gamma carboxyprothrombin; Liver cancer; PIVKA-II; Prothrombin induced by vitamin K absence or antagonist-I; TACE[SDGs]SDG3Prothrombin induced by vitamin K absence or antagonist-II (PIVKA-II) predicts complete responses of transarterial chemoembolization for hepatocellular carcinomajournal article10.1016/j.jfma.2022.01.005350786862-s2.0-85123237403WOS:000835288400026